- Home
- NVCT vs MRCC Comparison
NVCT vs MRCC Comparison
Compare NVCT & MRCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVCT
- MRCC
- Stock Information
- Founded
- NVCT 2020
- MRCC 2011
- Country
- NVCT United States
- MRCC United States
- Employees
- NVCT N/A
- MRCC N/A
- Industry
- NVCT Medicinal Chemicals and Botanical Products
- MRCC Investment Managers
- Sector
- NVCT Health Care
- MRCC Finance
- Exchange
- NVCT Nasdaq
- MRCC Nasdaq
- Market Cap
- NVCT 170.3M
- MRCC 176.4M
- IPO Year
- NVCT 2022
- MRCC 2012
- Fundamental
- Price
- NVCT $9.77
- MRCC $7.80
- Analyst Decision
- NVCT Strong Buy
- MRCC Hold
- Analyst Count
- NVCT 2
- MRCC 1
- Target Price
- NVCT $15.00
- MRCC $8.00
- AVG Volume (30 Days)
- NVCT 128.5K
- MRCC 80.3K
- Earning Date
- NVCT 05-06-2025
- MRCC 05-07-2025
- Dividend Yield
- NVCT N/A
- MRCC 12.85%
- EPS Growth
- NVCT N/A
- MRCC 2515.72
- EPS
- NVCT N/A
- MRCC 0.45
- Revenue
- NVCT N/A
- MRCC $60,527,000.00
- Revenue This Year
- NVCT N/A
- MRCC N/A
- Revenue Next Year
- NVCT N/A
- MRCC N/A
- P/E Ratio
- NVCT N/A
- MRCC $17.37
- Revenue Growth
- NVCT N/A
- MRCC N/A
- 52 Week Low
- NVCT $4.44
- MRCC $7.01
- 52 Week High
- NVCT $11.80
- MRCC $8.85
- Technical
- Relative Strength Index (RSI)
- NVCT 60.31
- MRCC 40.54
- Support Level
- NVCT $8.45
- MRCC $7.70
- Resistance Level
- NVCT $10.67
- MRCC $7.89
- Average True Range (ATR)
- NVCT 0.99
- MRCC 0.17
- MACD
- NVCT 0.08
- MRCC -0.00
- Stochastic Oscillator
- NVCT 72.98
- MRCC 28.99
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
About MRCC Monroe Capital Corporation
Monroe Capital Corp is a speciality finance company focused on providing financing to lower middle-market companies, in the U.S. and Canada. The company provides customized financing solutions focused on senior, unitranche, and junior secured debt and unsecured subordinated debt and equity, including equity co-investments in preferred and common stock and warrants.